GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » U2Bio Co Ltd (XKRX:221800) » Definitions » Price-to-Owner-Earnings

U2Bio Co (XKRX:221800) Price-to-Owner-Earnings : (As of Sep. 22, 2024)


View and export this data going back to 2015. Start your Free Trial

What is U2Bio Co Price-to-Owner-Earnings?

As of today (2024-09-22), U2Bio Co's share price is ₩3040.00. U2Bio Co does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for U2Bio Co's Price-to-Owner-Earnings or its related term are showing as below:

During the past 9 years, the highest Price-to-Owner-Earnings of U2Bio Co was 17.50. The lowest was 5.54. And the median was 7.34.


XKRX:221800's Price-to-Owner-Earnings is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 28.84
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-09-22), U2Bio Co's share price is ₩3040.00. U2Bio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was ₩-33.00. Therefore, U2Bio Co's PE Ratio for today is At Loss.

As of today (2024-09-22), U2Bio Co's share price is ₩3040.00. U2Bio Co's EPS without NRI for the trailing twelve months (TTM) ended in was ₩-34.46. Therefore, U2Bio Co's PE Ratio without NRI for today is At Loss.

During the past 9 years, U2Bio Co's highest PE Ratio without NRI was 76.20. The lowest was 0.00. And the median was 67.73.


U2Bio Co Price-to-Owner-Earnings Historical Data

The historical data trend for U2Bio Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U2Bio Co Price-to-Owner-Earnings Chart

U2Bio Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only - - 6.47 11.03 -

U2Bio Co Quarterly Data
Jun22 Mar23 Jun23 Mar24 Jun24
Price-to-Owner-Earnings - - - - -

Competitive Comparison of U2Bio Co's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, U2Bio Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


U2Bio Co's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, U2Bio Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where U2Bio Co's Price-to-Owner-Earnings falls into.



U2Bio Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

U2Bio Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=3040.00/-120.53
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


U2Bio Co  (XKRX:221800) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


U2Bio Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of U2Bio Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


U2Bio Co Business Description

Traded in Other Exchanges
N/A
Address
Basement 1, 68 Gumaro Songpagu, Seoul, KOR
U2Bio Co Ltd provides vitro diagnostic test services. The company is engaged in offering general diagnostic tests, molecular diagnostic tests, and breastfeeding nutritional analysis services among others.

U2Bio Co Headlines

No Headlines